Picture of Komipharm International Co logo

041960 Komipharm International Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareBalancedSmall CapHigh Flyer

Annual cashflow statement for Komipharm International Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-3,957-5,934-7,480-5,91114,690
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items1,7621,9794,879405-7,259
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-1,520-883-3,034-673-1,684
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities25.2-1,256-1,808-2,8008,847
Capital Expenditures-1,685-1,184-1,065-1,129-3,978
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items119439-310-2,3735,957
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-1,566-745-1,376-3,5021,979
Financing Cash Flow Items-647-1.11-37.9-6,362
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-1,640-1,0222,03410,531-13,231
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-3,830-3,057-1,1874,015-2,372